VITT and Second Doses of Covid-19 Vaccine.

Lacy, Joanne; Pavord, Sue; Brown, Kevin E

Lacy, Joanne; Pavord, Sue; Brown, Kevin E.

Lacy J; UK Health Security Agency, London, United Kingdom.
Pavord S; Oxford University, Oxford, United Kingdom.
Brown KE; UK Health Security Agency, London, United Kingdom kevin.brown@phe.gov.uk.

N Engl J Med ; 386(1): 95, 2022 01 06.

Article in English | MEDLINE | ID: covidwho-1585672

Subject(s)

COVID-19 Vaccines; ChAdOx1 nCoV-19/adverse effects; Immunization, Secondary; Thrombocytopenia/etiology; Thrombosis/etiology; Adult; Aged; Antibodies, Viral; COVID-19 Vaccines/adverse effects; Female; Humans; Male; Middle Aged; Platelet Factor 4/immunology; Purpura, Thrombocytopenic, Idiopathic/etiology; Recurrence; SARS-CoV-2/immunology; Spike Glycoprotein, Coronavirus/immunology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Thrombocytopenia / Thrombosis / Immunization, Secondary / COVID-19 Vaccines / ChAdOx1 nCoV-19 Topics: Vaccines Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: English Journal: N Engl J Med Year: 2022 Document Type: Article Affiliation country: NEJMc2118507

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google